EUVIMEDEUVIMED entdecken
Open Access

Individual disruption of 12 testis-enriched genes via the CRISPR/Cas9 system does not affect the fertility of male mice

Akira Suzuki, Norikazu Yabuta, Keisuke Shimada, Daisuke Mashiko, Keizo Tokuhiro, Yuki Oyama, Haruhiko Miyata, Thomas X Garcia, Martin M Matzuk, Masahito Ikawa

Journal of Reproductive Immunology · 2024-06 · 163 · 104252

DOI: 10.1016/j.jri.2024.104252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2024-06. Verfasst von Akira Suzuki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan; Department of Experimental Genome Research, Research Inst…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Testis, Mice, Knockout, Fertility. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, AMED, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsTestisMice, KnockoutFertilityInfertility, MaleSperm MotilityAnimalsMaleMiceFemaleGene EditingHumansMice, Inbred C57BL

Stichwörter der Autor:innen

CRISPR/Cas9Knockout miceMale infertilitySpermatozoaTestis

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan; Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871,…
  • Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan. Electronic address: nyabuta@biken.osaka-u.ac.jp.
  • Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
  • Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.
  • Department of Genome Editing, Institute of Biomedical Science, Kansai Medical University, Hirakata, Osaka 573-1191, Japan.
  • Center for Drug Discovery, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA; Scott Department of Urology, Baylor College of M…

Förderung

  • NICHD NIH HHS
  • AMED
  • Takeda Science Foundation
  • Japan Society for the Promotion of Science
  • NICHD
  • Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care

Zitieren

APA

Suzuki, A., Yabuta, N., Shimada, K., Mashiko, D., Tokuhiro, K., Oyama, Y., Miyata, H., Garcia, T. X., Matzuk, M. M., & Ikawa, M. (2024). Individual disruption of 12 testis-enriched genes via the CRISPR/Cas9 system does not affect the fertility of male mice. Journal of Reproductive Immunology, 163, 104252. https://doi.org/10.1016/j.jri.2024.104252

Vancouver

Suzuki A, Yabuta N, Shimada K, Mashiko D, Tokuhiro K, Oyama Y, et al. Individual disruption of 12 testis-enriched genes via the CRISPR/Cas9 system does not affect the fertility of male mice. Journal of Reproductive Immunology. 2024;163:104252. doi:10.1016/j.jri.2024.104252

BibTeX
@article{Suzuki2024,
  author = {Suzuki, Akira and Yabuta, Norikazu and Shimada, Keisuke and Mashiko, Daisuke and Tokuhiro, Keizo and Oyama, Yuki and Miyata, Haruhiko and Garcia, Thomas X and Matzuk, Martin M and Ikawa, Masahito},
  title = {Individual disruption of 12 testis-enriched genes via the CRISPR/Cas9 system does not affect the fertility of male mice},
  journal = {Journal of Reproductive Immunology},
  year = {2024},
  volume = {163},
  pages = {104252},
  doi = {10.1016/j.jri.2024.104252}
}
Kostenlos starten →